NCT00316329View on ClinicalTrials.gov

ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria

PHASE3CompletedINTERVENTIONAL

Enrollment

1,032

Participants

Timeline

Start Date

March 31, 2006

Conditions

Malaria

Interventions

DRUG

Artesunate + Amodiaquine

Trial Locations (5)

Unknown

CHU, Yaoundé

Centre de santé, Tsiroanomandidy

Bankoumana

Keur Socé

Oussouye

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00316329 - ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum Malaria | Biotech Hunter | Biotech Hunter